Why Hims & Hers Health Stock Is Skyrocketing Today
Shares of Hims & Hers Health Inc (NYSE: HIMS) are flying higher on Wednesday. The company's stock gained 21.7% as of 2:00 p.m. ET, and was up as much as 24.8% earlier in the day. The gain comes as the S&P 500 gained 0.1%, and the Nasdaq Composite was flat.Hims & Hers, a leading telehealth platform, announced today that it plans to introduce at-home testing for its customers after acquiring a new lab.The company acquired Trybe Labs, an at-home testing facility in New Jersey. The facilities will allow Hims to test blood samples sent through the mail. The company says that the at-home testing "will empower customers to take control of their health with deeper insights" and "help identify risk of disease before it develops."Continue reading

Shares of Hims & Hers Health Inc (NYSE: HIMS) are flying higher on Wednesday. The company's stock gained 21.7% as of 2:00 p.m. ET, and was up as much as 24.8% earlier in the day. The gain comes as the S&P 500 gained 0.1%, and the Nasdaq Composite was flat.
Hims & Hers, a leading telehealth platform, announced today that it plans to introduce at-home testing for its customers after acquiring a new lab.
The company acquired Trybe Labs, an at-home testing facility in New Jersey. The facilities will allow Hims to test blood samples sent through the mail. The company says that the at-home testing "will empower customers to take control of their health with deeper insights" and "help identify risk of disease before it develops."